LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXT and the CUSIP is 539319202. A total of 9 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $185,000 | -79.8% | 248,084 | -66.7% | 0.02% | -77.2% |
| Q1 2022 | $915,000 | -1.3% | 744,084 | -4.5% | 0.08% | +5.3% |
| Q4 2021 | $927,000 | -44.7% | 779,084 | -3.3% | 0.08% | -49.3% |
| Q3 2021 | $1,677,000 | -71.8% | 806,050 | -59.0% | 0.15% | -48.4% |
| Q2 2021 | $5,952,000 | +73.6% | 1,964,092 | +88.5% | 0.29% | -17.8% |
| Q1 2021 | $3,429,000 | – | 1,042,105 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ethos Financial Group, LLC | 248,084 | $205,240 | 0.06% |
| EP Wealth Advisors, LLC | 2,211 | $785,836 | 0.01% |
| Northeast Financial Consultants Inc | 20,000 | $16,546 | 0.00% |
| UBS Group AG | 10,722 | $8,867 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 24,901 | $20,601 | 0.00% |
| WELLS FARGO & COMPANY/MN | 53 | $44 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 101,209 | $84,003 | 0.00% |
| STATE STREET CORP | 35,956 | $29,843 | 0.00% |
| MORGAN STANLEY | 71,054 | $58,783 | 0.00% |